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Abstract
Aims: This study aimed to document and compare the nature of clinical pharmacists’ interventions made in different
practice settings within a children’s hospital.
Methods: The primary investigator observed and documented all clinical interventions performed by clinical pharmacists for
between 35–37 days on each of the five study wards from the three practice settings, namely general medical, general
surgical and hematology-oncology. The rates, types and significance of the pharmacists’ interventions in the different
settings were compared.
Results: A total of 982 interventions were documented, related to the 16,700 medication orders reviewed on the five wards
in the three practice settings over the duration of the study. Taking medication histories and/or patient counselling were
the most common pharmacists’ interventions in the general settings; constituting more than half of all interventions. On the
Hematology-Oncology Ward the pattern was different with drug therapy changes being the most common interventions
(n = 73/195, 37.4% of all interventions). Active interventions (pharmacists’ activities leading to a change in drug therapy)
constituted less than a quarter of all interventions on the general medical and surgical wards compared to nearly half on the
specialty Hematology-Oncology Ward. The majority (n = 37/42, 88.1%) of a random sample of the active interventions
reviewed were rated as clinically significant. Dose adjustment was the most frequent active interventions in the general
settings, whilst drug addition constituted the most common active interventions on the Hematology-Oncology Ward. The
degree of acceptance of pharmacists’ active interventions by prescribers was high (n = 223/244, 91.4%).
Conclusions: The rate of pharmacists’ active interventions differed across different practice settings, being most frequent in
the specialty hematology-oncology setting. The nature and type of the interventions documented in the hematology-
oncology were also different compared to those in the general medical and surgical settings.
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Introduction
Over the past decades, the traditional roles of clinical
pharmacists have expanded from compounding, dispensing and
supplying medicines to active participation in clinical activities.
This expanded role has increased the contribution of pharmacists,
as part of health care team, to minimize drug-related problems
and optimize patient outcomes [1]. Studies show that pharmacists
are crucial in medication misadventure reporting and they play an
important role in medication error prevention, especially when
participating in patient rounds [2]. Many specialist clinical units
such as neonatal critical care and oncology have relied on
pharmacist participation during clinical rounds in order to resolve
issues of adverse drug reactions, drug interactions and medication
errors associated with complexity of medical conditions and
medication regimens used in these units [3,4]. Clinical pharmacy
practices are prevalent in hospital settings in developed countries
like Australia, the United Kingdom, and the United States; yet the
nature and extent of the services provided appear to be highly
variable [5–7].
The precise meaning of the term pharmacists’ intervention is
still occasionally debated, but in Australia, there is generally broad
acceptance that a clinical pharmacy intervention is ‘any action by
a clinical pharmacist that directly results in a change in patient
management or therapy’ [8]. This definition appropriately
acknowledges that clinical pharmacists’ interventions only occur
if the pharmacist is able to influence the behavior of the prescriber
and other health care professionals such as nurses. Nevertheless, it
should be noted that in addition to intervening to resolve/prevent
actual/potential drug related problems, clinical pharmacists
perform a range of other important functions that might not
necessarily result in recommendations or direct changes in
medication management but these functions could rightly be
described as clinical pharmacy interventions [9]. For the purpose
of this study, the term of pharmacist’s intervention refers to any
action by a clinical pharmacist related to patient management or
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therapy and these can be classified as active and passive [8].
Passive interventions refer to care-centered activities not resulting
in medication changes and active interventions are those activities
leading to a change in drug therapy.
Previous studies have reported the contribution of clinical
pharmacists to patient care in a variety of clinical settings in
pediatrics [10–13]. In general, intervention data from those studies
has been aggregated for the purpose of analysis rather than
presented according to each clinical setting. Maat et al [10], did
however reported that in a study of interventions associated with
electronic prescription review, interventions were most frequently
conducted in the specialty units of immunology/hematology and
neurology compared to other units such as internal medicine.
Similarly, Barber et al [14], in a study involving children and
adults, reported higher rates of interventions in intensive care and
pediatrics/specialty wards (e.g. hematology, oncology, AIDS,
organ transplant) compared to other ward types. Therefore, this
study was conducted to document and compare the nature of
clinical pharmacists’ interventions made within different clinical
settings in a children’s hospital.
Methods
Setting
This study was conducted in a 220-bed pediatric teaching
hospital in Perth, Western Australia. Data were collected using
prospective non-disguised observational approach from Septem-
ber 2011 to August 2012 from three practice settings, namely
general medicine, general surgery and hematology-oncology.
There were three wards under general medicine, namely the
General Medical Ward for Infants, the General Medical Ward for
Young Children, and the General Medical Ward for Adolescents.
There was one ward assigned to general surgery and one to
hematology-oncology. The general medical wards are the acute
medical wards admitting patients under general pediatrics and a
range of non-oncology medical specialties, whilst the general
surgical ward admits patients under general surgery, ophthalmol-
ogy and otolaryngology. The principal researcher observed and
documented all interventions undertaken by clinical pharmacists
during their pharmacy rounds.
Pharmacists’ Interventions
During the data collection period, the primary investigator
observed and documented all clinical interventions performed by
the clinical pharmacists for between 35–37 days on each of the five
study wards from the three practice settings. Observation on non-
consecutive days was undertaken to avoid possible observation
fatigue of the pharmacists. During observation, the data collected
included the patient’s demographics, date of admission, diagnosis
on admission, medical history, medication history, adverse drug
reaction history, current medications, discharged date, the
description and the type of intervention, the medication(s)
involved, the cause of the intervention, the trigger of the
intervention, the intervened health care personnel, the degree of
acceptance of the intervention and the amount of time required to
do pharmacy rounds. The diagnosis on admission was classified
using the International Statistical Classification of Diseases and
Related Health Problems 10th Revision [15] for general medical
and general surgical wards, and the International Classification of
Childhood Cancer 3rd Edition/ICCC-3 with slight modifications
for diagnosis on Hematology-Oncology Ward [16]. The medica-
tions involved in the interventions were categorized using the
Australian Medicines Handbook (AMH) 2014 drug classes [17].
The types of interventions were categorized into major types with
further sub-categorization as described by Condren et al with
slight modifications [18]. The rates of interventions were defined
as the number of interventions per 100 medication orders
reviewed. In addition, the interventions were divided into active
and passive interventions as defined previously. The clinical
significance of randomly selected sample of pharmacists’ active
interventions (approximately 16% of active interventions) was
assessed by panel consisting of two of the investigators and two
independent hospital pharmacists. The consensus among the panel
members was used for the final rating.
Ethics Statement
This study was approved by the Princess Margaret Hospital
Institutional Review Board and Curtin University Human Ethics
Committee (No: PH-14-11). Written informed consent has been
obtained from the observed pharmacists prior to the commence-
ment of the study.
Data Analysis
Demographic variables and pharmacists’ intervention data were
summarized using descriptive statistics (mean 6 standard devia-
tion or median and range for variables measured on a continuous
scale, and frequencies and percentages for categorical variables).
Several pharmacists’ intervention related parameters among the
three practice settings were compared using Kruskal-Wallis
analysis. Data were analyzed using the SPSS version 19.0
(Chicago, IL, USA). The rates of pharmacists’ total interventions
and active interventions in the three settings were compared using
Poisson regression analysis using SAS version 9.2 (SAS Institute
Inc., Cary, NC). Poisson regression analysis was also performed to
determine the influence of the duration of pharmacy ward rounds
on pharmacists’ intervention rates.
Results
During the observation period of the study, 2891 patients were
reviewed by the clinical pharmacists in the three practice settings.
The basic demographic data of these patients are detailed in
Table 1. A total of 982 interventions were observed and
documented, which arose from 16,700 medication order reviews.
The breakdown of the pharmacists’ intervention data from each
clinical setting is summarized in Table 2 and the types of
interventions performed by the clinical pharmacists on the study
wards are outlined in Table 3. In terms of triggers leading to
interventions, the most frequent trigger was medication chart
review, with this monitoring activity being responsible for the
majority of interventions (79.3%) across all clinical settings.
As can be seen from the data in Table 2, the clinical
pharmacists made approximately 5–7 interventions per day. The
rates of intervention ranged from 5.63 to 10.48 interventions per
100 medication orders reviewed across the different settings. The
Poisson regression model showed that the rates of intervention
were significantly different across the three practice settings (p,
0.001). The rate of interventions appeared to be the highest in
general surgery, followed by general medicine and hematology-
oncology. It was observed that there was no significant difference
in the rates of interventions between general medicine and
hematology-oncology (p = 0.202), but the rate of intervention in
general surgical setting was significantly higher (P,0.001) than
that of the two other settings. On average, the pharmacists spent
approximately 49 minutes per ward round. The more time spent
on the ward rounds significantly increased the rate of interventions
across all clinical settings (p,0.001).
Pharmacists’ Interventions in a Children’s Hospital
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As can be seen from Table 3, taking medication histories and/
or patient counselling were the most common interventions
performed by the clinical pharmacists in the general medical and
surgical settings, with these activities constituting more than half of
all interventions. In contrast, the specialty unit, namely hematol-
ogy-oncology, had a different pattern of interventions; here drug
therapy changes were the most common interventions, represent-
ing around 37% of all interventions.
Active Pharmacists’ Interventions, Degree of Acceptance,
and Implicated Medications
Hematology-oncology had the highest rate of active interven-
tions (2.43/100 medication orders reviewed), followed by general
surgery (2.34) and general medicine (0.93). The rate of active
interventions in hematology-oncology was significantly higher
compared to general medicine (p,0.001) but not with general
surgery (p = 0.331). Meanwhile, the rates of active interventions
were not significantly influenced by the time spent on the ward
(p = 0.187). With regards to the clinical significance of active
interventions, the majority (n = 37/42, 88.1%) were rated as being
clinically significant. The significance of the interventions ranged
from not significant (12.8%), minor (46.2%), moderate (23.1%)
and major (17.9%); with no intervention thought to be life-saving.
Active interventions constituted less than a quarter of all
interventions on the general medical and surgical wards,
compared to 46.2% (p,0.001) on the Hematology-Oncology
Ward. Table 4 shows the distribution of the 244 active interven-
tions by type. For all active interventions, the degree of acceptance
was high at 91.4% (i.e. 223/244). ‘‘Adjusting the dose’’ was the
most frequent type of active intervention on both the general
medical and surgical wards. A slightly different trend was found on
the Hematology-Oncology Ward where the recommendations to
prescribe regular medications constituted the most common active
interventions (40%) followed by dose adjustment (26.7%). With
respect to the classes of medications implicated in active
interventions, anti-infectives were the drugs most often associated
with active interventions (n = 100), followed by analgesics (n = 46)
and drugs for the gastrointestinal system (n = 36), respectively.
Discussion
The prevalence of pharmacists’ interventions per 100 medica-
tion orders reviewed in this study ranged from 5.66 in general
medicine, 10.48 in general surgery, and 5.63 in hematology-
oncology The rate of intervention in the general surgical setting in
Table 1. Demographic Data of Patients in Three Clinical Settings.
Parameters General Medicine General Surgery Hematology-Oncology
Duration of study (days) 105 37 35
No. of patients 1936 514 441
Gender (%)
Male 939 (48.5) 311 (60.5) 279 (63.3)
Age* (years) 8.04 (0.02–19.00) 6.17 (0.06–17.00) 6.83 (0.35–17.00)
Length of stay* (days) 9.00 (1–95) 5.00 (1–71) 7.00 (1–82)
Types of medications*
Oral 3.00 (0–22) 3.00 (0–10) 4.00 (0–21)
Non-oral 1.00 (0–30) 2.00 (0–13) 3.00 (0–14)
*Median (Range).
doi:10.1371/journal.pone.0110168.t001
Table 2. The Pharmacists’ Interventions Documented in Three Clinical Settings.
Parameters General Medicine General Surgery Hematology-Oncology P-value
Duration of pharmacy round (minutes)# 50.5623.3 50.7619.0 41.7620.1 0.042*
(46.0–55.0) (44.4–57.0) (34.8–48.6)
No. of pharmacists’ interventions 516 271 195 -
Total number of medication orders reviewed 10494 2700 3506 -
No. of medication orders reviewed/day# 99.9640.6 72.9621.1 100.2633.0 0.001*
(92.1–107.8) (65.9–80.0) (88.8–111.5)
Rate of Pharmacists’ interventions per day# 4.963.8 7.460.8 5.660.6 0.014*
(4.2–5.7) (5.9–9.0) (4.4–6.8)
Rate of Pharmacists’ interventions
per 100 medication orders reviewed#
5.765.1 10.561.1 5.660.6 ,0.0011
(4.7–6.7) (8.3–12.7) (4.5–6.8)
#Denotes: Mean 6 Standard Deviation (95% Confidence Interval for Mean).
*Statistical analysis using Kruskal-Wallis test.
1Statistical analysis using Poisson regression.
doi:10.1371/journal.pone.0110168.t002
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our study was the highest compared to the other two settings (p,
0.05), although the surgical setting is often considered less complex
than general medical, intensive care or specialty areas [19]. In
comparison to the rates recorded in general medical settings in our
study, a higher active intervention rate (2.4/100 medication
orders) was reported from a study assessing the impact of
interventions performed by clinical pharmacists in reducing
prescribing errors in children hospitalized in a maternity and
children’s hospital in Spain [11]. However, the rate of active
interventions found on the Hematology-Oncology Ward in our
study was similar to that of the Spanish study. Unfortunately, the
Spanish study did not provide further information regarding the
nature of patients’ medical conditions. Presumably, active
intervention rates are influenced by the complexity of patients’
medication regimens.[10] This may account for our finding where
a higher incidence of active interventions was observed in the
hematology-oncology setting compared to other settings where
patients may have less complex conditions requiring less medica-
tion.
Aside from the number of medications prescribed, other factors
need to be taken into account as the predictors for pharmacists’
intervention rate. Consistent with our study, a large pharmacists’
interventions study in the UK, which included pediatric and adult
patients, found the time spent during ward rounds significantly
predicted the rates of the interventions [14]. In relation to the
clinical significance of active interventions, other studies involving
pediatric patients have had similar findings with around three-
quarters of the interventions having a positive impact on patient
care [11,20,21].
Table 3. Types of Pharmacists’ Interventions Documented in the Three Clinical Settings.
Intervention Categories [18] Number of Pharmacists’ Interventions (%)
General Medicine General Surgery Hematology-Oncology
(n=516) (n =271) (n=195)
Medication history and/or patient counselling 307 (59.5) 146 (53.9) 48 (24.6)
Drug therapy changes 65 (12.6) 50 (18.5) 73 (37.4)
Provision of drug information to other providers 57 (11.0) 27 (10.0) 52 (26.7)
Clarification of medication orders 52 (10.1) 35 (12.9) 3 (1.5)
Prevented adverse drug event (ADE) or medication error (ME) 23 (4.5) 8 (3.0) 16 (8.2)
Other 6 (1.2) 3 (1.1) 2 (1.0)
Occurrence of ADE or ME) 6 (1.2) 0 1 (0.5)
Drug interaction 0 1 (0.4) 0
Laboratory monitoring 0 1 (0.4) 0
doi:10.1371/journal.pone.0110168.t003
Table 4. Types of Active Interventions in the Three Clinical Settings.
Types of interventions Number of Active Interventions
General Medicine General Surgery Hematology-Oncology
(n=95) (n=59) (n =90)
Wrong/missing dose 36 21 24
Wrong/missing dosage interval/frequency 18 7 6
Drug added 10 8 36
Drug deleted 15 6 5
Antibiotic change 2 2 0
Wrong/missing therapy duration 1 0 6
Wrong/missing dosage form or strength 6 4 1
Regular to if required/if required to regular 1 6 3
Wrong/missing route 2 0 0
Scheduling error 1 0 3
Non formulary to formulary 0 3 0
MAR1 error 1 0 4
Other# 2 2 2
*Rates of active intervention per 100 medication orders, p value ,0.001 based on statistical analysis using Poisson regression.
1Denotes medication administration record.
#Other category includes wrong drug, intravenous to per oral change, wrong patient, illegible order, drug interaction.
doi:10.1371/journal.pone.0110168.t004
Pharmacists’ Interventions in a Children’s Hospital
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With respect to the pattern of pharmacists’ interventions,
activities related to taking medication histories and/or patient
counselling were the most frequent interventions in general
settings, whilst drug therapy changes were responsible for the
most frequent interventions in hematology-oncology setting. With
respect to intervention category, the subcategory of taking
medication histories and medication reconciliation activities
constituted the most common interventions performed by clinical
pharmacists in the general medical and surgical settings through-
out the study. This is not surprising given taking medication
histories and medication reconciliation are the initial steps in
reviewing patients and assessing the appropriateness of their
medications orders [22–24]. However, these activities occurred
less frequently in the hematology-oncology unit. The lower
proportion might be explained by the availability, completeness
and the ease of access to patients’ medical and medication histories
in this specialty setting. In addition, as the hematology and
oncology patients were admitted regularly to hospital for treatment
and monitoring, the health care providers including pharmacists
were familiar with the patients and their treatment protocols so the
pharmacists often looked at the patients’ records instead of
interviewing the patients and/or the parents.
There are limited published studies on pharmacists’ interven-
tions in a range of different clinical settings in pediatrics compared
to adult patients. Condren et al [23] conducted a self-reported
intervention study in a pediatric patient population including
general and intensive care inpatients and ambulatory patients. The
study reported 1.15 interventions per patient and the most
frequent intervention categories were drug therapy change, taking
medication history and/or patient counselling, and providing drug
information to other health care providers [18]. In addition, the
categories of common active interventions found by Condren et al
were consistent with the pattern of active interventions in the
hematology-oncology setting in our study [18].
In a 4-week study in 16 pediatric wards (9 specialist and 7
general wards) in the United Kingdom, interventions to resolve
improper dosing, incomplete prescriptions, and wrong frequency
were documented as the most common interventions performed
by pharmacists [25]. Dosing issues were also identified as the main
problem requiring pharmacists’ intervention in hospitalized
children in a Spanish study [11]. Likewise, a retrospective analysis
of 4 years of self-reported pharmacists’ interventions conducted by
Chan and colleagues involving pediatric patients in general and
specialty areas including hematology-oncology also detected
dosing issues as the major source of problems [13]. These studies
incorporating general and specialty settings [11,13,18,25] have
consistently shown that dosing-associated issues are the main
problem in pediatric patients. However those studies did not
provide further information regarding the breakdown of interven-
tions for each clinical setting so the pattern and rate of
interventions among the different settings, in particular general
versus specialty settings, in the child patient populations cannot be
compared and analyzed comprehensively. Nonetheless, a Dutch
study uncovered that the practice settings did influence the
intervention rate with interventions more common in immunol-
ogy/hematology and neurology compared to internal medicine
[10]. Further, Kaushal et al who conducted a study to assess the
rate of serious medication errors before and after the introduction
of unit-based clinical pharmacists in three units (intensive care
unit/ICU, general surgery and general medicine) in a US pediatric
hospital, reported that clinical pharmacists’ interventions substan-
tially decreased the rate of medication errors in the ICU whilst
there was no rate reduction in the general settings. The
investigators pointed out that the setting influenced the rates of
medication error-intercepting pharmacists’ interventions, in par-
ticular between the general and non-general settings such as ICU
[12].
In addition, the acceptance rate of the pharmacists’ active
recommendations was high across all settings in our study. This
rate of acceptance is similar to those found in other pediatric
studies [11,21,26]. This strengthen the established evidence
supporting the confidence of other health care providers have in
the significant contribution of pharmacists to improve the quality
of patient care in pediatric settings [12,18,27,28].
To the best of our knowledge, this is the first study that
compared the pharmacists’ interventions in a range of different
settings in pediatrics in terms of frequency, type, degree of
acceptance, clinical significance and medications implicated. It is
worthwhile noting that the majority of earlier studies on
pharmacists’ interventions were conducted using a self-reporting
approach by the intervening pharmacists. The prospective
observational approach used in this study allowed the observer
to obtain the actual number of interventions performed by ward
pharmacists to overcome the issues with self-reporting [29,30].
Nonetheless, a number of limitations need to be acknowledged in
this study. This study has been conducted in one pediatric hospital
which diminishes the ability to generalize the findings. Further, the
data has been collected on non-consecutive days to avoid
pharmacist observation fatigue which may influence the pattern
of the interventions. Another limitation is the difficulty in drawing
accurate comparisons with other intervention studies due to
considerable variations in settings, design, duration, size, method-
ology and definition of intervention.
In conclusion, the rate and nature of pharmacists’ interventions
appears to be influenced by the clinical setting. Specialty units, in
this case hematology-oncology, had a higher active intervention
rate as a result of more interventions related to drug therapy
changes compared to general medical and surgical units. The
findings of this study highlight the significance of pharmacists’
interventions in optimizing patient care in a range of pediatric
settings.
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